Pregnancy News and Research RSS Feed - Pregnancy News and Research Twitter

Males may play positive role in development of offspring's brains before pregnancy

Males may play positive role in development of offspring's brains before pregnancy

A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy. [More]
Study: Osteopathic manipulative therapy decreases low back pain by over 70% in postpartum women

Study: Osteopathic manipulative therapy decreases low back pain by over 70% in postpartum women

German researchers found osteopathic manipulative therapy (OMTh) decreased postpartum low back pain by over 70 percent in women who had given birth at least three months before beginning treatment, according to a new study published in July issue of the Journal of the American Osteopathic Association. [More]
Study: Umbilical cord milking improves blood pressure, red blood cell levels in preterm infants

Study: Umbilical cord milking improves blood pressure, red blood cell levels in preterm infants

A technique to increase the flow of blood from the umbilical cord into the infant's circulatory system improves blood pressure and red blood cell levels in preterm infants delivered by Cesarean section, according to a study funded by the National Institutes of Health. [More]
New research reveals that polluted Toronto neighbourhoods have high rates of childhood asthma

New research reveals that polluted Toronto neighbourhoods have high rates of childhood asthma

Children who develop asthma in Toronto are more likely to have been born in a neighbourhood that has a high level of traffic-related air pollution, new research suggests. [More]
Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

Caya contoured diaphragm to expand U.S. women's options for nonhormonal barrier contraception

With the launch of the Caya contoured diaphragm this June, women in the United States will have access to a method of contraception that is nonhormonal, has few side effects, and can be used for up to two years. Last fall, the United States Food and Drug Administration cleared the single-size Caya contoured diaphragm for marketing in the US, and now the diaphragm is available by prescription from healthcare providers. [More]
New report on global market for point of care diagnostics

New report on global market for point of care diagnostics

The market for point of care diagnostics reached $17 billion, in 2014, according to Kalorama Information. The term refers to diagnostic tests performed outside the central laboratory or decentralized. [More]
MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA) today announced that on 22 June the European Commission approved SIMPONI (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA). [More]
WHO prequalifies new male circumcision device to prevent HIV

WHO prequalifies new male circumcision device to prevent HIV

The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use. [More]
FDA provides safety update about Essure Birth Control Implant

FDA provides safety update about Essure Birth Control Implant

The FDA first announced their intention to provide a safety update about Essure late yesterday evening. Today's much anticipated report comes on the heals of a private citizen petition that raised serious concerns about the Essure Birth Control Implant and resulted in the launch of an FDA investigation into the birth control device. [More]
Groundbreaking UVA research may lead to creation of male contraceptive

Groundbreaking UVA research may lead to creation of male contraceptive

Groundbreaking new reproductive research from the School of Medicine has identified key molecular events that could be playing a critical role as sperm and egg fuse to create new life. The findings might one day lead to the creation of a male contraceptive. [More]
Bariatric surgery can significantly reduce urinary incontinence

Bariatric surgery can significantly reduce urinary incontinence

For severely obese people, bariatric surgery may have a benefit besides dramatic weight loss: it can also substantially reduce urinary incontinence. [More]
PROMISSE study: Most women with lupus can expect good pregnancy outcomes

PROMISSE study: Most women with lupus can expect good pregnancy outcomes

One of the most important and anxiety-producing concerns among patients with lupus is whether it is safe to become pregnant. A pioneering study led by researchers at Hospital for Special Surgery has shown that most women can expect a good pregnancy outcome if their lupus is inactive and they are free of certain risk factors. [More]
UT Southwestern researchers identify two proteins within fetal lungs that initiate labor process

UT Southwestern researchers identify two proteins within fetal lungs that initiate labor process

Researchers at UT Southwestern Medical Center have identified two proteins in a fetus' lungs responsible for initiating the labor process, providing potential new targets for preventing preterm birth. [More]
Stress during pregnancy affects babies' brain development

Stress during pregnancy affects babies' brain development

Stress during the first trimester of pregnancy alters the population of microbes living in a mother's vagina. Those changes are passed on to newborns during birth and are associated with differences in their gut microbiome as well as their brain development, according to a new study by University of Pennsylvania researchers. [More]
Michael Charness named recipient of Henry Rosett Award for FASD research

Michael Charness named recipient of Henry Rosett Award for FASD research

Michael Charness, MD, professor of neurology and associate dean of veterans affairs at Boston University School of Medicine and Chief of Staff of the VA Boston Health Care System has been selected by the Rosett Committee of the Fetal Alcohol Spectrum Disorders Study Group as the 2015 recipient of the Henry Rosett Award for Outstanding Contributions to the Fetal Alcohol Spectrum Disorders (FASD) field. [More]

Improved birth control advice reduces unintended pregnancy rate among young women

Providing health workers with training on how to educate young women about intrauterine devices (IUDs) and contraceptive implants reduced the rate of unintended pregnancy by almost half in a study of women seeking family planning services. [More]
The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Eli Lilly and Company announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated CYRAMZA (ramucirumab) as a second-line treatment for people with hepatocellular carcinoma (HCC), also known as liver cancer. While the REACH trial's primary endpoint of overall survival favored the CYRAMZA arm, it was not statistically significant. [More]
Human breast milk bought online poses serious health risks

Human breast milk bought online poses serious health risks

The recent craze for human breast milk, which has become a lucrative online market, poses serious health risks, according to British experts. [More]
Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Amgen today announced that a Phase 3 study evaluating Vectibix (panitumumab) and best supportive care (BSC) met its primary endpoint, demonstrating a statistically significant improvement in overall survival (OS) in patients with chemorefractory wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC) compared to those patients treated with BSC alone. [More]
Compass Group USA wins Best Employers for Healthy Lifestyles award

Compass Group USA wins Best Employers for Healthy Lifestyles award

Compass Group USA was named as a 2015 National Business Group on Health Best Employer for Healthy Lifestyles for its ongoing commitment and dedication to promoting a healthy work environment and encouraging their associates and families to maintain healthy lifestyles. [More]
Advertisement
Advertisement